Coronavirus Vaccine

Coronavirus Vaccine

More Stories on Coronavirus Vaccine
United Nations

World leaders return to UN with focus on COVID-19 pandemic, climate change

Sep 19, 2021

As the coronavirus still rages amid an inequitable vaccine rollout, about a third of the 193 UN states are planning to again send videos

Union Health Minister Mansukh Mandaviya

80 cr COVID-19 vaccine doses administered in country, says Health Minister

Sep 18, 2021

On Friday, India administered the highest ever single-day vaccinations with 2.5 crore doses given in 24 hours, which Union Health Minister Mansukh Mandaviya described as a golden chapter in world history

Union Health Minister Mansukh Mandaviya

India crosses landmark of administering 75 crore Covid vaccine doses: Health Minister

Sep 13, 2021

So far, all adult people in six states and union territories -- Sikkim, Himachal Pradesh, Goa, Dadra and Nagar Haveli, Ladakh and Lakshadweep -- have received at least one dose of the vaccine.

On August 25, the ministry had notified Drone Rules, 202, that liberalised the regulatory regime over drones

Govt grants ICMR conditional permission to use drones for vaccine delivery

Sep 13, 2021

The ICMR has been permitted to use drones up to a height of 3,000 metre to deliver vaccines, the Civil Aviation Ministry's statement added

Moderna's COVID-19 vaccine is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson & Johnson, suggests a new study

Moderna's COVID-19 vaccine more effective against Delta variant than Pfizer, J&J, reveals study

Sep 11, 2021

Published in Morbidity and Mortality Weekly Report, the study indicates that Moderna was 95% effective at preventing hospitalisation among adults aged 18 years and older, while Pfizer was 80% effective and J&J was 60% effective

Moderna provided updates on its ongoing mid-stage trial testing its authorized COVID-19 vaccine in children aged 6 months to less than 12 years

Moderna working on single-dose booster shot for COVID-19, flu

Sep 09, 2021

"Our number one priority as a company right now is to bring to market a Pan-respiratory annual booster vaccine, which we plan to always customize and upgrade," Chief Executive Officer Stéphane Bancel said during Moderna's R&D day

Sputnik V is based on a proven and well-studied platform of human adenoviral vectors

Panacea Biotec supplies first shipment of Sputnik V component II developed in India

Sep 07, 2021

The batch will be distributed in India through Dr Reddy's Laboratories. To date, Sputnik V has been authorised in 70 countries

With a fourth wave of infections, more Americans are turning to ivermectin, a cheap drug used to kill worms and other parasites in humans and animals

US health experts warn against taking ivermectin to treat COVID-19

Sep 04, 2021

Large studies are now underway in the US and overseas to determine if the drug has any effect on preventing or blunting COVID-19

India stopped the export of Covid vaccines in mid-April

India to start exporting COVID-19 vaccine after local public health needs are met

Sep 02, 2021

"Even the public health response to Covid is governed by those goals. So we will also try to achieve those goals and see when would be the right time to export vaccines," said Union Health Secretary Rajesh Bhushan

Booster dose can wait, says AIIMS Chief Randeep Guleria

Booster dose can wait, need to vaccinate everyone first: AIIMS Chief Randeep Guleria

Aug 26, 2021

“I think we should focus on vaccinating those who have not been vaccinated till now, especially the high-risk group," said Guleria

Vaccines for healthy children not before 2022: Head of govt's vaccine panel

Aug 25, 2021

 Dr NK Arora has stated that vaccines for healthy children will be available by the “ first quarter of 2022”. “Children with co-morbidities are more likely to develop severe diseases and hence they will be prioritised,” he said. Right now, India has given emergency use authorisation to one vaccine for kids above the age of 12. “This vaccine will be rolled out by October,” he said.